Sandoz Enters New Era as Standalone Global Leader and European Champion in Generic and Biosimilar Medicines

Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz shares included in key market indices Standalone Sandoz committed to extend leadership in stable and growing market via purpose-driven strategy with focus on sustainable access Differentiating investment grade credit profile and six strategic levers to drive long-term value Basel, October [...]